Phil Morton

Chief Technology Officer • Albumedix

Dr Philip Morton has a strong technology background with over 25 years’ experience in the biopharmaceutical industry within process and product development as well as product application research. He was trained as a biochemical engineer and has biopharmaceutical experience in both R&D and manufacturing environments in Albumedix under its former owners of Delta Biotechnology, Aventis and Novozymes. He current heads up biotechnology innovation within Albumedix in both the production and use of its’ products.

Also Speaking

Lucas De Breed

Founder and Managing Director • August Care

James Wang

Chief Technology Officer • Juventas Cell Therapy

Joseph (Yossi) Schwartz

Medical Director, Transfusion Medicine Quality Assurance • Mount Sinai Health System

Event Info


Fun Run